# Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary Intervention

> **NCT01360437** · PHASE3 · COMPLETED · sponsor: **University of Patras** · enrollment: 44 (actual)

## Conditions studied

- Coronary Artery Disease
- Acute Coronary Syndrome

## Interventions

- **DRUG:** Prasugrel
- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT01360437
- **Lead sponsor:** University of Patras
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2012-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01360437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01360437, "Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary Intervention". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01360437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*